Literature DB >> 18957432

Mechanisms of RNA-mediated disease.

Jason R O'Rourke1, Maurice S Swanson.   

Abstract

Recent mapping of functional sequence elements in the human genome has led to the realization that transcription is pervasive and that noncoding RNAs compose a significant portion of the transcriptome. Some dominantly inherited neurological disorders are associated with the expansion of microsatellite repeats in noncoding regions that result in the synthesis of pathogenic RNAs. Here, we review RNA gain-of-function mechanisms underlying three of these microsatellite expansion disorders to illustrate how some mutant RNAs cause disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957432      PMCID: PMC2658036          DOI: 10.1074/jbc.R800025200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  RNA folding in vivo.

Authors:  Renée Schroeder; Rupert Grossberger; Andrea Pichler; Christina Waldsich
Journal:  Curr Opin Struct Biol       Date:  2002-06       Impact factor: 6.809

2.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.

Authors:  Rob Willemsen; Marianne Hoogeveen-Westerveld; Surya Reis; Joan Holstege; Lies-Anne W F M Severijnen; Ingeborg M Nieuwenhuizen; Mariette Schrier; Leontine van Unen; Flora Tassone; Andre T Hoogeveen; Paul J Hagerman; Edwin J Mientjes; Ben A Oostra
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

3.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

4.  Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR.

Authors:  B Tian; R J White; T Xia; S Welle; D H Turner; M B Mathews; C A Thornton
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

5.  Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse.

Authors:  Kamel Khalili; Luis Del Valle; Vandhana Muralidharan; William J Gault; Nune Darbinian; Jessica Otte; Ellen Meier; Edward M Johnson; Dianne C Daniel; Yayoi Kinoshita; Shohreh Amini; Jennifer Gordon
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

6.  RNA structure of trinucleotide repeats associated with human neurological diseases.

Authors:  Krzysztof Sobczak; Mateusz de Mezer; Gracjan Michlewski; Jacek Krol; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

7.  RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila.

Authors:  Peng Jin; Daniela C Zarnescu; Fuping Zhang; Christopher E Pearson; John C Lucchesi; Kevin Moses; Stephen T Warren
Journal:  Neuron       Date:  2003-08-28       Impact factor: 17.173

Review 8.  A decade of molecular studies of fragile X syndrome.

Authors:  William T O'Donnell; Stephen T Warren
Journal:  Annu Rev Neurosci       Date:  2002-03-20       Impact factor: 12.449

Review 9.  New insights into fragile X syndrome: from molecules to neurobehaviors.

Authors:  Peng Jin; Stephen T Warren
Journal:  Trends Biochem Sci       Date:  2003-03       Impact factor: 13.807

10.  Genetic and chemical modifiers of a CUG toxicity model in Drosophila.

Authors:  Amparo Garcia-Lopez; Lidon Monferrer; Irma Garcia-Alcover; Marta Vicente-Crespo; M Carmen Alvarez-Abril; Ruben D Artero
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

View more
  60 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 2.  RNA-mediated neurodegeneration in repeat expansion disorders.

Authors:  Peter K Todd; Henry L Paulson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

3.  Reducing levels of toxic RNA with small molecules.

Authors:  Leslie A Coonrod; Masayuki Nakamori; Wenli Wang; Samuel Carrell; Cameron L Hilton; Micah J Bodner; Ruth B Siboni; Aaron G Docter; Michael M Haley; Charles A Thornton; J Andrew Berglund
Journal:  ACS Chem Biol       Date:  2013-09-27       Impact factor: 5.100

4.  Nanopore analysis of individual RNA/antibiotic complexes.

Authors:  Meni Wanunu; Swati Bhattacharya; Yun Xie; Yitzhak Tor; Aleksei Aksimentiev; Marija Drndic
Journal:  ACS Nano       Date:  2011-11-16       Impact factor: 15.881

Review 5.  Regulation of mRNA translation in renal physiology and disease.

Authors:  Balakuntalam S Kasinath; Denis Feliers; Kavithalakshmi Sataranatarajan; Goutam Ghosh Choudhury; Myung Ja Lee; Meenalakshmi M Mariappan
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-17

6.  Making sense of the antisense transcripts in C9FTD/ALS.

Authors:  Peter K Todd
Journal:  Acta Neuropathol       Date:  2013-12       Impact factor: 17.088

7.  Two ways to misregulate mRNAs in myotonic dystrophy.

Authors:  Rodger B Voelker; J Andrew Berglund
Journal:  Nat Struct Mol Biol       Date:  2010-02       Impact factor: 15.369

Review 8.  RNA processing and its regulation: global insights into biological networks.

Authors:  Donny D Licatalosi; Robert B Darnell
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

Review 9.  Motifs from the deep.

Authors:  Tony W Hwang; Vlad Codrea; Andrew D Ellington
Journal:  J Biol       Date:  2009-09-02

Review 10.  Paraspeckles: nuclear bodies built on long noncoding RNA.

Authors:  Charles S Bond; Archa H Fox
Journal:  J Cell Biol       Date:  2009-08-31       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.